241.58
price down icon0.55%   -1.33
after-market Handel nachbörslich: 241.58
loading
Schlusskurs vom Vortag:
$242.91
Offen:
$243.63
24-Stunden-Volumen:
961.07K
Relative Volume:
0.72
Marktkapitalisierung:
$33.69B
Einnahmen:
$2.12B
Nettoeinkommen (Verlust:
$-309.19M
KGV:
-105.77
EPS:
-2.2841
Netto-Cashflow:
$93.57M
1W Leistung:
+4.47%
1M Leistung:
+2.63%
6M Leistung:
+75.29%
1J Leistung:
+40.60%
1-Tages-Spanne:
Value
$240.57
$249.26
1-Wochen-Bereich:
Value
$226.66
$250.00
52-Wochen-Spanne:
Value
$125.38
$256.36

Natera Inc Stock (NTRA) Company Profile

Name
Firmenname
Natera Inc
Name
Telefon
650-249-9090
Name
Adresse
13011 MCCALLEN PASS, AUSTIN, CA
Name
Mitarbeiter
4,434
Name
Twitter
@nateragenetics
Name
Nächster Verdiensttermin
2024-11-12
Name
Neueste SEC-Einreichungen
Name
NTRA's Discussions on Twitter

Vergleichen Sie NTRA mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Diagnostics & Research icon
NTRA
Natera Inc
241.58 33.87B 2.12B -309.19M 93.57M -2.2841
Diagnostics & Research icon
TMO
Thermo Fisher Scientific Inc
625.98 240.25B 43.74B 6.58B 6.11B 17.31
Diagnostics & Research icon
DHR
Danaher Corp
235.01 169.58B 24.27B 3.50B 5.02B 4.8589
Diagnostics & Research icon
IDXX
Idexx Laboratories Inc
693.85 55.18B 4.17B 1.03B 940.22M 12.61
Diagnostics & Research icon
IQV
Iqvia Holdings Inc
235.31 40.71B 15.90B 1.28B 2.21B 7.2842
Diagnostics & Research icon
A
Agilent Technologies Inc
135.05 39.30B 6.95B 1.30B 1.15B 4.5696

Natera Inc Stock (NTRA) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2026-01-07 Eingeleitet Citigroup Buy
2025-12-02 Fortgesetzt Morgan Stanley Overweight
2025-10-27 Hochstufung BNP Paribas Exane Underperform → Neutral
2025-09-22 Fortgesetzt Wells Fargo Equal Weight
2025-03-13 Eingeleitet RBC Capital Mkts Outperform
2025-01-23 Eingeleitet Barclays Overweight
2024-06-03 Fortgesetzt Jefferies Buy
2024-04-08 Fortgesetzt Craig Hallum Buy
2024-02-20 Herabstufung Raymond James Strong Buy → Outperform
2023-12-29 Bestätigt BTIG Research Buy
2023-12-14 Eingeleitet Guggenheim Buy
2023-12-13 Eingeleitet Wolfe Research Outperform
2023-11-13 Hochstufung Raymond James Outperform → Strong Buy
2023-09-28 Eingeleitet Bernstein Mkt Perform
2023-07-05 Fortgesetzt JP Morgan Overweight
2023-05-05 Eingeleitet UBS Buy
2023-01-18 Hochstufung Raymond James Mkt Perform → Outperform
2022-08-25 Eingeleitet Credit Suisse Outperform
2022-04-25 Eingeleitet Stephens Overweight
2022-03-08 Eingeleitet Goldman Buy
2022-01-06 Fortgesetzt Piper Sandler Overweight
2021-10-15 Fortgesetzt Cowen Outperform
2021-06-15 Eingeleitet Raymond James Mkt Perform
2021-05-25 Eingeleitet Wells Fargo Overweight
2021-01-28 Eingeleitet Truist Buy
2020-10-08 Eingeleitet BTIG Research Buy
2020-09-28 Eingeleitet Morgan Stanley Overweight
2020-09-17 Eingeleitet SVB Leerink Outperform
2020-06-10 Fortgesetzt Piper Sandler Overweight
2020-05-07 Hochstufung JP Morgan Neutral → Overweight
2018-10-05 Eingeleitet JP Morgan Neutral
2018-07-05 Bestätigt Piper Jaffray Overweight
2017-08-07 Bestätigt Morgan Stanley Overweight
2016-11-10 Bestätigt The Benchmark Company Buy
2016-05-23 Bestätigt The Benchmark Company Buy
2016-05-11 Bestätigt The Benchmark Company Buy
2016-04-19 Eingeleitet The Benchmark Company Buy
2015-09-28 Hochstufung Wedbush Neutral → Outperform
2015-08-14 Hochstufung Morgan Stanley Equal-Weight → Overweight
2015-08-04 Eingeleitet Robert W. Baird Outperform
2015-07-27 Eingeleitet Morgan Stanley Equal-Weight
2015-07-27 Eingeleitet Piper Jaffray Overweight
2015-07-27 Eingeleitet Wedbush Neutral
Alle ansehen

Natera Inc Aktie (NTRA) Neueste Nachrichten

pulisher
05:59 AM

iA Global Asset Management Inc. Acquires Shares of 6,659 Natera, Inc. $NTRA - MarketBeat

05:59 AM
pulisher
04:21 AM

GDS Wealth Management Has $11.61 Million Holdings in Natera, Inc. $NTRA - MarketBeat

04:21 AM
pulisher
Jan 24, 2026

Is It Too Late To Consider Natera (NTRA) After A 4x Three Year Share Price Surge - Yahoo Finance

Jan 24, 2026
pulisher
Jan 24, 2026

How Natera Inc. (NTRA) Affects Rotational Strategy Timing - Stock Traders Daily

Jan 24, 2026
pulisher
Jan 23, 2026

How Investors May Respond To Natera (NTRA) MRD Breakthrough, AI Push And 2025 Revenue Outlook - simplywall.st

Jan 23, 2026
pulisher
Jan 23, 2026

Fesko John, president at Natera, sells $4.2 million in NTRA stock By Investing.com - Investing.com India

Jan 23, 2026
pulisher
Jan 23, 2026

Fesko John, president at Natera, sells $4.2 million in NTRA stock - Investing.com India

Jan 23, 2026
pulisher
Jan 23, 2026

Lack of Natera (NTRA) Exposure Weighs on Mid-Cap Fund Performance - Insider Monkey

Jan 23, 2026
pulisher
Jan 23, 2026

Lack of Natera (NTRA) Exposure Weighs on Voya MidCap Opportunities Fund Performance - Yahoo Finance

Jan 23, 2026
pulisher
Jan 23, 2026

Universal Beteiligungs und Servicegesellschaft mbH Buys 19,166 Shares of Natera, Inc. $NTRA - MarketBeat

Jan 23, 2026
pulisher
Jan 23, 2026

Allstate Corp Makes New $775,000 Investment in Natera, Inc. $NTRA - MarketBeat

Jan 23, 2026
pulisher
Jan 22, 2026

Natera (NASDAQ:NTRA) Insider John Fesko Sells 339 Shares - MarketBeat

Jan 22, 2026
pulisher
Jan 22, 2026

Solomon Moshkevich Sells 293 Shares of Natera (NASDAQ:NTRA) Stock - MarketBeat

Jan 22, 2026
pulisher
Jan 22, 2026

Natera CEO Chapman sells $17.2 million in shares - Investing.com

Jan 22, 2026
pulisher
Jan 22, 2026

Insider Selling: Natera (NASDAQ:NTRA) CEO Sells 1,590 Shares of Stock - MarketBeat

Jan 22, 2026
pulisher
Jan 22, 2026

Natera (NASDAQ:NTRA) CEO Steven Leonard Chapman Sells 71,932 Shares - MarketBeat

Jan 22, 2026
pulisher
Jan 22, 2026

Solomon Moshkevich Sells 23,205 Shares of Natera (NASDAQ:NTRA) Stock - MarketBeat

Jan 22, 2026
pulisher
Jan 22, 2026

Natera (NASDAQ:NTRA) Insider John Fesko Sells 17,806 Shares - MarketBeat

Jan 22, 2026
pulisher
Jan 22, 2026

Natera CFO Brophy sells $14.6 million in NTRA stock By Investing.com - Investing.com UK

Jan 22, 2026
pulisher
Jan 22, 2026

Natera CFO Brophy sells $14.6 million in NTRA stock - Investing.com

Jan 22, 2026
pulisher
Jan 22, 2026

Natera CEO Chapman sells $17.2 million in shares By Investing.com - Investing.com UK

Jan 22, 2026
pulisher
Jan 22, 2026

Natera co-founder Sheena Jonathan sells $1.44m in NTRA stock By Investing.com - Investing.com Nigeria

Jan 22, 2026
pulisher
Jan 22, 2026

Natera president sells $5.5 million in NTRA stock By Investing.com - Investing.com Nigeria

Jan 22, 2026
pulisher
Jan 22, 2026

Natera co-founder Sheena Jonathan sells $1.44m in NTRA stock - Investing.com UK

Jan 22, 2026
pulisher
Jan 22, 2026

Natera’s sec. Daniel Rabinowitz sells $4.6m in NTRA stock - Investing.com

Jan 22, 2026
pulisher
Jan 22, 2026

Natera president sells $5.5 million in NTRA stock - Investing.com

Jan 22, 2026
pulisher
Jan 22, 2026

Natera Executives and Director Engage in Significant Stock Transactions - TradingView

Jan 22, 2026
pulisher
Jan 22, 2026

Natera Expands MRD Ambitions With Latitude Study And AI NVIDIA Deal - simplywall.st

Jan 22, 2026
pulisher
Jan 22, 2026

Aubrey Capital Management Ltd Takes $2.61 Million Position in Natera, Inc. $NTRA - MarketBeat

Jan 22, 2026
pulisher
Jan 21, 2026

Rakuten Investment Management Inc. Acquires New Position in Natera, Inc. $NTRA - MarketBeat

Jan 21, 2026
pulisher
Jan 21, 2026

Natera (NTRA) Unveils Promising Study Results for Colorectal Can - GuruFocus

Jan 21, 2026
pulisher
Jan 21, 2026

Natera Publishes Clinical Validation of Latitude™ Tissue-Free MRD Test in Colorectal Cancer - Yahoo Finance

Jan 21, 2026
pulisher
Jan 20, 2026

Natera to present EXPAND trial data on fetal genetic screening By Investing.com - Investing.com India

Jan 20, 2026
pulisher
Jan 20, 2026

Natera (NTRA) Surged as Results Beat Expectations - Insider Monkey

Jan 20, 2026
pulisher
Jan 20, 2026

Natera to present EXPAND trial data on fetal genetic screening - Investing.com

Jan 20, 2026
pulisher
Jan 20, 2026

Natera’s Fetal Focus™ Single Gene NIPT (sgNIPT) Selected for Prestigious Oral Plenary Presentation at Society of Maternal Fetal Medicine (SMFM) Meeting - Yahoo Finance

Jan 20, 2026
pulisher
Jan 20, 2026

Campbell & CO Investment Adviser LLC Acquires Shares of 5,145 Natera, Inc. $NTRA - MarketBeat

Jan 20, 2026
pulisher
Jan 19, 2026

Natera raises 2025 revenue guidance to $2.18B–$2.26B amid record Signatera growth and increased gross margin - MSN

Jan 19, 2026
pulisher
Jan 19, 2026

Massachusetts Financial Services Co. MA Sells 17,498 Shares of Natera, Inc. $NTRA - MarketBeat

Jan 19, 2026
pulisher
Jan 18, 2026

Assessing Natera (NTRA) Valuation After AI Oncology Advances And Strong 2025 Growth Guidance - simplywall.st

Jan 18, 2026
pulisher
Jan 17, 2026

Short Interest in Natera, Inc. (NASDAQ:NTRA) Rises By 39.8% - MarketBeat

Jan 17, 2026
pulisher
Jan 16, 2026

Natera prenatal test false advertising $8.25M class action settlement explained: Are you owed money? - Claim Depot

Jan 16, 2026
pulisher
Jan 16, 2026

AI-Enhanced Signatera Upgrade And NVIDIA Deal Could Be A Game Changer For Natera (NTRA) - simplywall.st

Jan 16, 2026
pulisher
Jan 14, 2026

Is It Too Late To Consider Natera (NTRA) After Its Strong 1-Year Share Price Run? - simplywall.st

Jan 14, 2026
pulisher
Jan 14, 2026

Natera Targets Endometrial Cancer With New Signatera Trial, Expanding Its MRD Opportunity - TipRanks

Jan 14, 2026
pulisher
Jan 14, 2026

Sumitomo Mitsui Trust Group Inc. Sells 88,968 Shares of Natera, Inc. $NTRA - MarketBeat

Jan 14, 2026
pulisher
Jan 14, 2026

Assessing Whether Natera (NTRA) Is Overvalued After Strong Longer Term Share Price Gains - Yahoo Finance

Jan 14, 2026
pulisher
Jan 14, 2026

Natera unveils AI model to enhance cancer recurrence risk assessment By Investing.com - Investing.com Nigeria

Jan 14, 2026
pulisher
Jan 13, 2026

How Investors Are Reacting To Natera (NTRA) NVIDIA-Backed Multimodal AI And Precision Diagnostics Advances - Yahoo Finance

Jan 13, 2026
pulisher
Jan 13, 2026

NTRA & NVDA Partner to Improve AI Models for Precision Medicine - sharewise.com

Jan 13, 2026
pulisher
Jan 13, 2026

Natera’s SCORE Study Builds Real-World Evidence for Cancer MRD Testing - TipRanks

Jan 13, 2026

Finanzdaten der Natera Inc-Aktie (NTRA)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
diagnostics_research A
$135.05
price down icon 2.58%
diagnostics_research MTD
$1,406.36
price down icon 2.21%
diagnostics_research IQV
$235.31
price down icon 1.56%
diagnostics_research WAT
$392.31
price down icon 2.03%
$150.28
price down icon 2.38%
Kapitalisierung:     |  Volumen (24h):